文献速递肾移植血液净化与透析慢性肾脏病

欧洲儿童期肾脏替代治疗成人结局:2008-2019年ERA登记研究

Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

该研究基于欧洲21国ERA登记数据,纳入2944例2008-2019年间满18岁的儿童期起始肾脏替代治疗患者,分析其转为成人后的特征、治疗轨迹及结局。结果显示未调整5年患者生存率96.9%,透析患者死亡风险显著高于肾移植受者(校正HR 5.44),18岁肾移植和透析患者预期寿命分别较一般人群短17年和40年。

要点

  • 儿童期起始KRT的成人幸存者5年生存率96.9%,但透析患者死亡风险是肾移植受者的5.44倍
  • 18岁肾移植和透析患者预期寿命分别较一般人群短17年和40年
  • 18至23岁期间约21%肾移植受者丧失移植物,34%透析患者继续透析

核心结论

  • 18岁肾移植受者预期寿命仍低于一般人群,但拥有功能肾移植的结局优于透析。
  • 18至23岁期间约五分之一肾移植失败,三分之一透析患者继续透析。

研究设计与样本

  • 基于欧洲肾脏协会登记系统,收集21个欧洲国家/地区2008-2019年间满18岁的儿童期起始KRT患者个体数据,共2944例。
  • 分析患者特征和治疗轨迹,采用Kaplan-Meier法和Cox比例风险回归进行患者和移植物生存分析。

主要发现

  • 起始KRT年龄为0-4岁的成人幸存者比例及抢先肾移植比例均增加。
  • 未调整5年患者生存率为96.9%(95%CI 96.2-97.5)。
  • 透析患者死亡风险高于肾移植受者,校正HR为5.44(95%CI 3.34-8.86)。
  • 18至23岁期间,约21%的成人幸存者丧失肾移植,34%的透析患者继续透析。
  • 与一般人群相比,18岁肾移植和透析患者的预期寿命分别短17年和40年。

临床怎么用

  • 儿童期起始KRT的成人幸存者过渡至成人肾科时,应关注移植肾功能丧失和持续透析的风险。
  • 对于18岁仍透析的患者,需积极评估肾移植以改善长期生存。
  • 18至23岁是肾移植失败和持续透析的高风险窗口,需加强随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Young adults starting kidney replacement therapy (KRT) during childhood and reaching their 18th birthday (i.e. adult survivors of childhood KRT) form a challenging population of interest to nephrologists treating adults, as during this period there will be a transition to adult renal centres. Nonetheless, few studies have focused on the epidemiology of KRT in this group. We aimed to provide an update on these patients' characteristics, treatment history, and graft and patient survival, to report their 5-year prognosis and expected remaining lifetime. METHODS: Data on KRT patients reaching their 18th birthday in 2008-19 were collected from 21 European countries/regions providing individual patient data to the European Renal Association (ERA) Registry. Patient characteristics and treatment trajectories were examined before and after turning 18 years old. Kaplan-Meier and Cox proportional hazards regression were used for patient and graft survival analyses. RESULTS: In total, 2944 patients were included. The proportion of adult survivors initiating KRT at a very young age (0-4 years) and undergoing pre-emptive kidney transplantation increased. Unadjusted 5-year patient survival was 96.9% [95% confidence interval (CI) 96.2-97.5]. Dialysis patients had a higher risk of death than kidney transplant recipients [adjusted hazard ratio 5.44 (95% CI 3.34-8.86)]. Between ages 18 and 23 years, about 21% of the adult survivors lost their kidney transplant and 34% of the dialysis patients continued this treatment. Compared with the general population, life expectancy for 18-year-old kidney transplant and dialysis patients was 17 and 40 years shorter, respectively. CONCLUSION: Life expectancy of 18-year-old kidney transplant recipients was lower compared with the general population, yet having a functioning kidney graft at age 18 years resulted in better outcomes than being on dialysis. Nevertheless, between ages 18 and 23 years, about one-fifth of the kidney grafts failed and one-third of the patients remained on dialysis.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Montez de Sousa IR, Bonthuis M, Kramer A, et al. Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study. Nephrol Dial Transplant. 2025. PMID: 39182157. doi:10.1093/ndt/gfae189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。